Fairvalue-Calculator Fairvalue-Calculator
EN DE

Jiangxi Synergy Pharmaceutical Co (300636) Fair Value & Analysis

Healthcare · CN · Market cap 2.8B CNY

Price¥6.52
Fair Value¥3.83
Upside-41.3%
Quality95/100
Evidence: Medium Range ¥2.87 – ¥4.56

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Jiangxi Synergy Pharmaceutical Co (300636) currently trades at ¥6.52, while our model-based Fair Value estimate is ¥3.83 — implying the stock looks roughly 41.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepressants, as well as antigout and urinary system medications. It also exports its products to Europe, the United States, Japan, South Korea, and other regions. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is Jiangxi Synergy Pharmaceutical Co (300636) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥3.83 versus a price of ¥6.52 — about −41% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 300636?
Our 21-model fair value for Jiangxi Synergy Pharmaceutical Co is ¥3.83 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥6.52.
What is the quality score of 300636?
Jiangxi Synergy Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.